Oklo is trading at $44.81, down -7.45%, amid broader valuation and milestone-related pressure.
- No new company-specific announcement explaining the August 10 decline was identified; coverage cites no single confirmed catalyst.
- The move follows Fridayβs 14.77% rally after Q2 results and Groves reactor criticality news.
- Q2 news was mixed: revenue beat expectations, but losses widened and spending guidance increased.